Delivery Order SPE2DB24D8002-SPE2DB24FJMUL
Award Date
8/21/24
Potential Completion Date
8/22/24
Potential Value
$4.7K
Federal Agency
Defense Logistics Agency
Awardee
Dakota Drug, Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Anoka, MN, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded a $11,011.62 firm fixed-price delivery order contract to Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation. The contract is to provide the DLA with 4564860861 - FLUTICASONE-SALMETEROL 230-21 12GM, a pharmaceutical product used to treat asthma and COPD. The contract has an ultimate completion date of June 11, 2024 and was awarded on June...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $3,317.13, is for the delivery of the pharmaceutical product Fluticasone-Salmeterol 115-21 12GM. The contract has an ultimate completion date of February 25, 2025. Dakota Drug, Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA, SPE2DB24D8001, valued at $999,999,999.00, as...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The $2,437.20 firm fixed-price delivery order contract is for the supply of Fluticasone-Salmeterol 115-21 12GM, a pharmaceutical product. The contract has an ultimate completion date of June 3, 2024. Dakota Drug, Inc. is an established vendor in the federal medical supply market, holding a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA...
This is a $4,303.40 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the supply of FLUTICASONE-SALMETEROL 230-21 12GM, a pharmaceutical product, with a performance period ending on January 31, 2024. This award does not utilize any set-aside designation. As a prime contractor with over two decades of experience serving the Department of Defense and...
This contract award, valued at $1,524.99, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the delivery of Fluticasone-Salmeterol 115-21 12GM, a pharmaceutical product. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and an ultimate completion date of February 13, 2025. Dakota Drug, Inc. holds a larger, single-award Indefinite Delivery Contract (IDC) with the DLA, valued at...
This federal contract award, valued at $3,381.49, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business located in Anoka, Minnesota. The contract is for the delivery of Fluticasone-Salmeterol 115-21 12GM, a respiratory medication, with a completion date of May 8, 2025. Dakota Drug, Inc. holds a significant Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999.00, as part of the DLA Troop Support Medical's ECAT...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Dakota Drug, Inc., a self-certified small disadvantaged business, for the supply of the pharmaceutical product "FLUTICASONE-SALMETEROL 115-21 12GM". The contract has a potential value of $11,906.17 and a completion date of February 21, 2024. Dakota Drug, Inc. is an experienced federal contractor, having served as a prime to the DLA Troop Support Medical for over two...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $3,476.84, is for the delivery of Fluticasone-Salmeterol 45-21 12GM, a pharmaceutical product. The contract does not have a set-aside designation and is set to be completed by October 29, 2024. Dakota Drug, Inc. is a key supplier to the DLA Troop Support Medical division, providing a range of pharmaceutical...
This is a federal contract award from the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business that specializes in providing pharmaceutical products, medical supplies, and healthcare equipment to the U.S. federal government. The contract, valued at $7,225.70, is a firm fixed-price delivery order for the supply of Fluticasone-Salmeterol 115-21 12GM inhalers. The award is associated with a larger Indefinite Delivery Contract (IDC) between Dakota...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Dakota Drug, Inc., a self-certified small disadvantaged business, for the supply of the pharmaceutical product Fluticasone-Salmeterol 115-21 12GM. The contract has a ceiling value of $8,385.19 and an ultimate completion date of March 26, 2024. There is no set-aside designation for this award. Dakota Drug, Inc. has over two decades of experience as a prime contractor to the federal...